Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals
Influenza and Other Respiratory Viruses · 2024
DOI: 10.1111/irv.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Yuan Gao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Antiviral Agents, Ritonavir, Artificial Intelligence, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High-Level Public Health Technology Talent Project, Construction Project of High-level Technology Talents in Public Health.
Abstract (Originalsprache)
Introduction
There is still a lack of clinical evidence comprehensively evaluating the effectiveness of antiviral treatments for COVID‐19 hospitalized patients.
Methods
A retrospective cohort study was conducted at Beijing You'An Hospital, focusing on patients treated with nirmatrelvir/ritonavir or azvudine. The study employed a tripartite analysis—viral dynamics, survival curve analysis, and AI‐based radiological analysis of pulmonary CT images—aiming to assess the severity of pneumonia.
Results
Of 370 patients treated with either nirmatrelvir/ritonavir or azvudine as monotherapy, those in the nirmatrelvir/ritonavir group experienced faster viral clearance than those treated with azvudine (5.4 days vs. 8.4 days, p < 0.001). No significant differences were observed in the survival curves between the two drug groups. AI‐based radiological analysis revealed that patients in the nirmatrelvir group had more severe pneumonia conditions (infection ratio is 11.1 vs. 5.35, p = 0.007). Patients with an infection ratio higher than 9.2 had nearly three times the mortality rate compared to those with an infection ratio lower than 9.2.
Conclusions
Our study suggests that in real‐world studies regarding hospitalized patients with COVID‐19 pneumonia, the antiviral effect of nirmatrelvir/ritonavir is significantly superior to azvudine, but the choice of antiviral agents is not necessarily linked to clinical outcomes; the severity of pneumonia at admission is the most important factor to determine prognosis. Additionally, our findings indicate that pulmonary AI imaging analysis can be a powerful tool for predicting patient prognosis and guiding clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fourth Department of Liver Disease Center, Beijing You'An Hospital, Capital Medical University, Beijing, China.
- School of Management, University of Science and Technology of China, Hefei, China.
- Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.
- Department of Radiology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
- School of Basic Medicine, Qingdao University, Qingdao, China.
- Department of Urology, Beijing You'An Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yuan Gao
Förderung
- High-Level Public Health Technology Talent Project
- Construction Project of High-level Technology Talents in Public Health
Zitieren
APA
Gao, Y., Dong, Y., Bu, Q., Gong, Z., Wang, W., Zhou, Z., Gao, Y., Liu, L., Wu, M., Zhang, J., Liang, L., Li, H., Jiang, M., Luo, Z., Ma, Y., Zhang, X., & Hu, Z. (2024). Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70006
Vancouver
Gao Y, Dong Y, Bu Q, Gong Z, Wang W, Zhou Z, et al. Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70006
BibTeX
@article{Gao2024,
author = {Gao, Yuan and Dong, Yixi and Bu, Qiushi and Gong, Zhijie and Wang, Wei and Zhou, Zhongkai and Gao, Yunyi and Liu, Liwei and Wu, Menghua and Zhang, Jiaying and Liang, Lianchun and Li, Hongjun and Jiang, Mengxi and Luo, Zujin and Ma, Yingmin and Zhang, Xinyu and Hu, Zhongjie},
title = {Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
doi = {10.1111/irv.70006}
}
EUVIMED